Czech National Bank Acquires 1,601 Shares of Humana Inc. (NYSE:HUM)

Czech National Bank raised its position in Humana Inc. (NYSE:HUM - Free Report) by 6.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,709 shares of the insurance provider's stock after purchasing an additional 1,601 shares during the quarter. Czech National Bank's holdings in Humana were worth $7,332,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. 180 Wealth Advisors LLC grew its stake in shares of Humana by 7.9% in the 1st quarter. 180 Wealth Advisors LLC now owns 1,393 shares of the insurance provider's stock valued at $369,000 after buying an additional 102 shares in the last quarter. Rhumbline Advisers raised its position in Humana by 3.3% during the first quarter. Rhumbline Advisers now owns 246,037 shares of the insurance provider's stock valued at $65,101,000 after acquiring an additional 7,909 shares in the last quarter. Fifth Third Wealth Advisors LLC grew its position in Humana by 8.6% in the first quarter. Fifth Third Wealth Advisors LLC now owns 1,237 shares of the insurance provider's stock worth $327,000 after acquiring an additional 98 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Humana by 40,881.1% during the 1st quarter. GAMMA Investing LLC now owns 781,099 shares of the insurance provider's stock worth $2,066,790,000 after purchasing an additional 779,193 shares during the last quarter. Finally, Versant Capital Management Inc increased its stake in shares of Humana by 17.1% during the 1st quarter. Versant Capital Management Inc now owns 453 shares of the insurance provider's stock worth $120,000 after purchasing an additional 66 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HUM. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Oppenheimer boosted their price target on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Barclays decreased their price target on Humana from $322.00 to $273.00 and set an "equal weight" rating for the company in a research note on Monday. Wall Street Zen raised Humana from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Truist Financial reduced their target price on Humana from $325.00 to $305.00 and set a "hold" rating for the company in a report on Monday, May 12th. Sixteen investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus target price of $284.48.

Humana Price Performance

NYSE:HUM traded down $2.70 during mid-day trading on Wednesday, hitting $230.72. The company's stock had a trading volume of 1,105,597 shares, compared to its average volume of 1,775,703. The company has a market capitalization of $27.85 billion, a price-to-earnings ratio of 23.19, a P/E/G ratio of 2.05 and a beta of 0.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The stock has a fifty day moving average of $255.59 and a 200-day moving average of $265.99.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the company posted $7.23 EPS. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.